(Q43820678)

English

Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime

scientific article published on 4 December 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime (English)

1 reference

Europe PubMed Central

27 November 2017

Klebsiella pneumoniae

0 references

Escherichia coli

1 reference

based on heuristic

inferred from title

author name string

Annie Wong-Beringer

1

1 reference

Europe PubMed Central

27 November 2017

Janet Hindler

2

1 reference

Europe PubMed Central

27 November 2017

Michael Loeloff

3

1 reference

Europe PubMed Central

27 November 2017

Anne Marie Queenan

4

1 reference

Europe PubMed Central

27 November 2017

Nancy Lee

5

1 reference

Europe PubMed Central

27 November 2017

David A Pegues

6

1 reference

Europe PubMed Central

27 November 2017

John P Quinn

7

1 reference

Europe PubMed Central

27 November 2017

Karen Bush

8

1 reference

Europe PubMed Central

27 November 2017

language of work or name

0 references

publication date

4 December 2001

1 reference

Europe PubMed Central

27 November 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

27 November 2017

34

1 reference

Europe PubMed Central

27 November 2017

2

1 reference

Europe PubMed Central

27 November 2017

135-146

1 reference

Europe PubMed Central

27 November 2017

Properties of plasmids responsible for production of extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1086%2F324742

21 January 2018

Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamase

1 reference

https://api.crossref.org/works/10.1086%2F324742

21 January 2018

Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1086%2F324742

21 January 2018

Treatment of a meningitis due to an Enterobacter aerogenes producing a derepressed cephalosporinase and a Klebsiella pneumoniae producing an extended-spectrum beta-lactamase.

1 reference

https://api.crossref.org/works/10.1086%2F324742

21 January 2018

Novel beta-lactamase in a clinical isolate of Klebsiella pneumoniae conferring unusual resistance to beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1086%2F324742

21 January 2018

Successful treatment of ceftazidime-resistant Klebsiella pneumoniae ventriculitis with intravenous meropenem and intraventricular polymyxin B: case report and review

1 reference

https://api.crossref.org/works/10.1086%2F324742

21 January 2018

Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients

1 reference

https://api.crossref.org/works/10.1086%2F324742

21 January 2018

Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1086%2F324742

21 January 2018

Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility

1 reference

https://api.crossref.org/works/10.1086%2F324742

21 January 2018

Outbreak of extended spectrum beta lactamase producing Klebsiella pneumoniae in a neonatal unit

1 reference

https://api.crossref.org/works/10.1086%2F324742

21 January 2018

Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins

1 reference

https://api.crossref.org/works/10.1086%2F324742

21 January 2018

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.

1 reference

https://api.crossref.org/works/10.1086%2F324742

21 January 2018

Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella

1 reference

https://api.crossref.org/works/10.1086%2F324742

21 January 2018

A functional classification scheme for beta-lactamases and its correlation with molecular structure

1 reference

https://api.crossref.org/works/10.1086%2F324742

21 January 2018

Identifiers

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43820678&oldid=2103643585"